Pan-JAK Inhibitors (Almirall)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePan-JAK Inhibitors (Almirall)
Drug Alias NamePurinone derivatives
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitorsTyrosine-protein kinase JAK2 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK3Tyrosine-protein kinase JAK1
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlmirall Sa
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A